Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3827001 | 0.98 | CES2 (0.32) | CES2 | |
| SCHEMBL21810576 | 0.76 | — | — | |
| SCHEMBL10524575 | 0.76 | — | — | |
| SCHEMBL1895685 | 0.75 | — | — | |
| SCHEMBL16139838 | 0.74 | CES2 (0.54) | CES2 | |
| SCHEMBL486218 | 0.72 | — | — | |
| SCHEMBL2325983 | 0.71 | CA2 (0.30) | — | |
| SCHEMBL7949809 | 0.70 | CES2 (0.31) | CES2 | |
| SCHEMBL9618300 | 0.67 | CES2 (0.32) | CES2 | |
| SCHEMBL11630550 | 0.67 | ALDH1A1 (0.33) | CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025091685-A1 | FLUORINATED LIQUID COMPOSITION AND USE THEREOF | 深圳市鸿富诚新材料股份有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-114702460-B | Method for synthesizing 2H-1, 3-oxazine compound by utilizing micro-channel reaction device | 南京工业大学 | 2024-05-31 | — | — | CN | claimed |
| CN-117603661-A | Fluorinated liquid composition and application thereof | 武汉肯达科讯科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-114874418-B | Conjugated polymer based on trifluoromethyl substituted quinoxaline, and preparation method and application thereof | 广东聚石科技研究有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-114524777-B | Synthesis method of dihydro-oxazole compound | 南京先进生物材料与过程装备研究院有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-115010641-A | Beta-substituted pyrrole derivative, preparation method and application thereof | 青岛农业大学 | 2022-09-06 | — | — | CN | claimed |
| CN-114874418-A | Conjugated polymer based on trifluoromethyl substituted quinoxaline and preparation method and application thereof | 广东聚石科技研究有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114702460-A | Method for synthesizing 2H-1, 3-oxazine compound by using microchannel reaction device | 南京工业大学 | 2022-07-05 | — | — | CN | claimed |
| CN-114524777-A | Synthesis method of dihydrooxazole compound | 南京先进生物材料与过程装备研究院有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-110878099-B | Preparation method of pyrrole [1,2, alpha ] indole alkaloid derivative | 五邑大学 | 2021-11-30 | — | — | CN | claimed |
| CN-110878099-A | Preparation method of pyrrole [1,2, α ] indole alkaloid derivative | 五邑大学 | 2020-03-13 | — | — | CN | claimed |
| EP-2098501-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE FLUORINE-CONTAINING CARBONYL-ENE PRODUCT | CENTRAL GLASS CO LTD (JP) | 2017-08-23 | — | — | EP | claimed |
| US-8278479-B2 | Method for producing optically active fluorine-containing carbonyl-ene product | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-10-02 | — | — | US | claimed |
| US-20090312574-A1 | Method for Producing Optically Active Fluorine-Containing Carbonyl-ene Product | CENTRAL GLASS COMPANY, LIMITED (JP) | 2009-12-17 | — | — | US | claimed |
| EP-2098501-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE FLUORINE-CONTAINING CARBONYL-ENE PRODUCT | Central Glass Company, Limited (JP) | 2009-09-09 | — | — | EP | claimed |
| EP-3433239-B1 | SMALL MOLECULE INHIBITORS OF THE NUCLEAR TRANSLOCATION OF ANDROGEN RECEPTOR FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4651872-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS | Septerna, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2000042026-A1 | NON-PEPTIDE GLP-1 AGONISTS | NOVO NORDISK A/S (DK) | 2000-07-20 | — | — | WO | disclosed |
| US-4803298-A | Process for the preparation of perfluoroalkyl ketones | RHONE-POULENC CHIMIE (FR) | 1989-02-07 | — | — | US | disclosed |
| US-4357282-A | CONTACTING A FLUORINATED METHYL OR ETHYL EHTER HAVING A METHOXYLATED CARBON ATOM WITH A LEWIS ACID CATALYST ACYLATION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312574-A1 | Method for Producing Optically Active Fluorine-Containing Carbonyl-ene Product | KCNE1, KHK, FOXO1 | CES2 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.